Search

everythinglearnresearchcommunity

for

Search:↓

The document says there are five types of hair loss conditions and different causes, including drugs.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

A systematic approach is crucial for managing hair loss in women.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.